Skip to main content

Health & Medicine

AstraZeneca CEO Says AI Improving Drug Development Success Rates

Source: MarketScreener
AstraZeneca CEO Says AI Improving Drug Development Success Rates

AstraZeneca's CEO reports that artificial intelligence is enhancing the company's drug development success rates, potentially accelerating the pace of bringing new medications to market. The statement highlights AI's growing role in pharmaceutical research and development as a key competitive advantage for the company.

Read Full Article at MarketScreener

Related Articles